Colorectal cancer used to be described, almost reflexively, as a disease of aging. That description no longer fits the data: incidence in adults under 50 has roughly doubled each decade over the past 20 years in numerous countries, and researchers have spent years searching for an explanation that fits patients with no family history and few conventional risk factors.
A 2025 study published in Nature offered one of the most compelling leads yet: a bacterial toxin called colibactin, potentially encountered during early childhood, decades before diagnosis. The hypothesis does not explain every case, and the researchers behind it have framed their findings as a strong lead rather than a settled cause.
Why Young-Onset Colorectal Cancer Has Become a Research Priority
Young-onset colorectal cancer generally refers to cases diagnosed before age 50. Cancer registries in at least 27 countries have documented rising incidence in this group, even as rates in older adults have held steady or declined, partly from improved screening. If current trends continue, it is projected to become the leading cause of cancer death among young adults by 2030.
What makes this trend puzzling is that many young patients lack the risk factors typically associated with the disease, including family history, obesity, or hypertension. That absence is exactly why researchers began looking further back in a patient’s life, at exposures that occurred long before symptoms appeared.
The Gut Microbiome During Childhood
The gut microbiome, the community of bacteria in the digestive tract, develops rapidly in infancy, shaped by birth method, diet, antibiotics, and environmental contact. This developmental window sets patterns that can persist, in modified form, for decades.
Diet during these early years influences which bacterial species thrive in the gut, while antibiotic exposure can disrupt microbial balance in ways that sometimes favor the survival of specific bacterial strains. Infection history, environmental sanitation, and immune system development all interact with this early microbiome in ways researchers are still working to fully map.
Where Bacterial Toxins Enter the Story
Bacterial genotoxins are compounds produced by certain bacteria that can directly damage the DNA of host cells they come into contact with. Colibactin, the toxin at the center of this research, is produced by specific strains of Escherichia coli that live naturally in the human colon and rectum.
Not all E. coli produce colibactin, and many strains are harmless components of a normal gut microbiome. But colibactin-producing strains have the capacity to introduce distinctive DNA damage patterns into the cells lining the colon, and researchers have identified this damage as a mutational signature that can be detected years, even decades, after the initial exposure occurred.
From Early Exposure to Adult Cancer: The Proposed Biological Pathway
The proposed mechanism follows a sequence: early childhood exposure to colibactin-producing bacteria leads to colonization of the gut, followed by ongoing toxin exposure that causes cellular DNA damage in colon cells. This damage can result in specific mutations, including alterations to genes like APC that are among the earliest known drivers of colorectal cancer development. Over subsequent decades, these early mutations may increase susceptibility to the disease appearing at a younger age than would otherwise be expected.
Researchers reported that colibactin-related mutational signatures were roughly 3.3 times more common in patients diagnosed before age 40 compared with those diagnosed after age 70, and that these mutations account for approximately 15% of early APC driver mutations found in colorectal cancer overall. According to the study’s authors, acquiring a driver mutation by age 10 could theoretically shift the disease timeline forward by decades, potentially producing a diagnosis at 40 instead of 60.
What the Research Can and Cannot Prove
This research is built on genomic analysis of tumor samples from patients across many countries, identifying mutational signatures consistent with colibactin exposure. That approach provides strong circumstantial evidence linking early-life exposure to the mutations found decades later in tumors, but it is not the same as directly observing the exposure occur and then tracking those same children into adulthood.
Human observational research of this kind establishes correlation between a mutational signature and a disease outcome, not proof that the exposure single-handedly caused the cancer. Animal models have supported the plausibility of the mechanism, and laboratory evidence has clarified how colibactin damages DNA. Even so, the study’s own senior researchers have publicly cautioned that further work is necessary to establish direct causality, distinguishing a strongly supported hypothesis from a fully proven cause.
Other Explanations for Rising Young Onset Colorectal Cancer
Colibactin exposure is one proposed contributor among several being actively studied. Obesity and broader metabolic health changes over recent decades have paralleled the rise in early-onset cases. Dietary shifts, including increased consumption of processed foods and reduced fiber intake, remain an active area of investigation.
Alcohol consumption, physical inactivity, and various environmental exposures have all been proposed as contributing factors, alongside genetic predispositions in a subset of younger patients. Improved screening has also increased detection in some populations, though researchers generally agree this accounts for only part of the observed increase, since incidence trends predate many recent screening expansions. Most researchers in this field believe multiple factors interact rather than a single cause explaining the entire trend.
| Proposed Factor | Type of Evidence | Current Status |
|---|---|---|
| Colibactin exposure | Genomic mutational signature analysis | Strong emerging hypothesis, not yet proven causal |
| Obesity and metabolic changes | Population trend correlation | Established risk factor, contribution to trend unclear |
| Dietary changes | Observational and mechanistic | Active area of research |
| Reduced physical activity | Observational | Established general risk factor |
| Environmental exposures | Limited, exploratory | Early-stage investigation |
| Genetics | Family and cohort studies | Explains a minority of cases |
What Researchers Need to Learn Next
Future research priorities include longitudinal childhood cohorts that could track microbiome development and later cancer risk directly, rather than relying on retrospective mutational analysis. Advanced microbiome sequencing techniques could help identify exactly how and when children acquire colibactin-producing bacterial strains.
Better exposure measurement tools, potentially including stool-based tests for colibactin-associated mutations, are already in early development according to the researchers involved. Molecular tumor analysis across more diverse populations would help clarify why some countries show sharper rises in young-onset cases than others. Prospective studies, following exposed and unexposed children over time, would ultimately be needed to move this hypothesis from strong association toward established causation.
Early life microbiome research offers a genuinely promising lead in explaining part of the young-onset colorectal cancer trend, but the pattern of rising cases almost certainly reflects multiple interacting factors rather than any single explanation. Continued research across diet, environment, genetics, and microbial exposure will likely be necessary before the full picture comes into focus.
FAQ
Q: What causes young-onset colorectal cancer?
A: The exact cause is not fully understood, but researchers believe multiple factors contribute, including a proposed link to childhood exposure to a bacterial toxin called colibactin, along with obesity, diet, and other lifestyle and environmental factors.
Q: Can gut bacteria cause colorectal cancer?
A: Certain strains of gut bacteria produce a toxin called colibactin that can damage DNA in colon cells, and research has found this damage pattern more frequently in early-onset colorectal cancer cases, though direct causation has not been fully established.
Q: What is colibactin?
A: Colibactin is a genotoxic compound produced by specific strains of Escherichia coli that live in the human colon, capable of altering the DNA of nearby cells.
Q: Does childhood microbiome exposure affect adult cancer risk?
A: Research suggests early childhood may be a critical exposure window for certain bacterial toxins linked to later mutation patterns in colorectal cancer, though this research is still developing.
Q: Why is colorectal cancer increasing among younger adults?
A: The increase likely reflects multiple interacting factors, including proposed bacterial exposure, obesity, dietary changes, reduced physical activity, and possibly improved detection in some populations.
Q: Can diet change gut bacteria linked with cancer?
A: Diet is known to influence gut bacterial composition generally, and researchers are actively studying whether specific dietary patterns affect colonization by colibactin-producing bacteria, though this remains an active research question.
Q: How much more common is colibactin damage in young patients?
A: One study found colibactin-related mutational signatures were about 3.3 times more common in patients diagnosed before age 40 compared with those diagnosed after age 70.
Q: Is this bacterial link a proven cause of colorectal cancer?
A: No. Researchers describe it as a strongly supported hypothesis based on genomic evidence, but they have stated that further research is needed to establish direct causation.